Sumitomo Mitsui Trust Group
GH icon

Sumitomo Mitsui Trust Group’s Guardant Health GH Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7M Sell
404,816
-78,951
-16% -$8.59M 0.03% 406
2026
Q1 		$44.7M Sell
483,767
-156,738
-24% -$15.7M 0.03% 477
2025
Q4 		$65.4M Sell
640,505
-113,649
-15% -$10.2M 0.04% 389
2025
Q3 		$47.1M Sell
754,154
-1,276,484
-63% -$69.4M 0.03% 491
2025
Q2 		$106M Buy
2,030,638
+673,411
+50% +$30.1M 0.07% 274
2025
Q1 		$57.8M Sell
1,357,227
-106,986
-7% -$4.62M 0.04% 401
2024
Q4 		$44.7M Buy
1,464,213
+238,037
+19% +$6.7M 0.03% 479
2024
Q3 		$28.1M Buy
1,226,176
+1,137,482
+1,282% +$32.2M 0.02% 592
2024
Q2 		$2.56M Sell
88,694
-229,000
-72% -$5.33M ﹤0.01% 809
2024
Q1 		$6.55M Sell
317,694
-26,051
-8% -$558K ﹤0.01% 805
2023
Q4 		$9.3M Buy
343,745
+231,904
+207% +$6.08M 0.01% 775
2023
Q3 		$3.31M Sell
111,841
-102
-0.1% -$3.59K ﹤0.01% 870
2023
Q2 		$4.01M Buy
111,943
+3,745
+3% +$108K ﹤0.01% 849
2023
Q1 		$2.54M Buy
108,198
+29,886
+38% +$854K ﹤0.01% 892
2022
Q4 		$2.13M Sell
78,312
-5,903
-7% -$270K ﹤0.01% 929
2022
Q3 		$4.53M Buy
+84,215
New +$4.32M ﹤0.01% 854
2021
Q2 		– Sell
-148,614
Closed -$22.7M – 1194
2021
Q1 		$22.7M Buy
148,614
+15,966
+12% +$2.41M 0.01% 697
2020
Q4 		$17.1M Sell
132,648
-9,546
-7% -$1.1M 0.01% 722
2020
Q3 		$15.9M Sell
142,194
-123,067
-46% -$11.3M 0.01% 718
2020
Q2 		$21.5M Sell
265,261
-121,988
-32% -$9.83M 0.02% 670
2020
Q1 		$27M Buy
387,249
+10,942
+3% +$840K 0.02% 584
2019
Q4 		$29.4M Buy
376,307
+113,239
+43% +$8.16M 0.02% 615
2019
Q3 		$16.8M Buy
263,068
+52,637
+25% +$4.64M 0.01% 672
2019
Q2 		$18.2M Buy
+210,431
New +$16.1M 0.02% 671

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group's GH Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Guardant Health (GH) stake by 16% in Q2 2026, selling an estimated $8.59M and leaving 404,816 shares worth $60.7M. The position accounts for 0.03% of the portfolio, ranked #406.

Sumitomo Mitsui Trust Group first reported a position in GH in Q2 2019 and has held it in 24 quarters since. The position peaked at $106M in Q2 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 404,816 shares of Guardant Health worth $60.7M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 78,951 Guardant Health shares in Q2 2026, an estimated $8.59M.
  • Guardant Health made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #406 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Guardant Health in Q2 2019 and has held it in 24 quarters since.
  • Sumitomo Mitsui Trust Group's Guardant Health position peaked at $106M in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.